D614G and Omicron SARS-CoV-2 variant spike proteins differ in the effects of N-glycan modifications on spike expression, virus infectivity, and neutralization by some therapeutic antibodies https://www.biorxiv.org/content/10.1101/2023.05.10.540228v1?med=mas